Akero Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Akero Therapeutics

09/08/2024 15:21

* Akero Therapeutics Inc  AKRO.OQ  reported a quarterly
adjusted
loss of 81 cents​​ per share for the quarter ended in June,
lower than the same quarter last year, when the company reported
EPS of -60 cents.  The mean expectation of eight analysts for
the quarter was for a loss of 90 cents per share. Wall Street
expected results to range from $-1.15 to -64 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Akero Therapeutics Inc's reported EPS for the quarter was
a loss
of 81 cents​.
    * The company reported a quarterly loss of $55.99 million.
    * Akero Therapeutics Inc shares had risen by 6.3% this
quarter and
gained 6.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 2% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Akero
Therapeutics Inc is $46.00 
This summary was machine generated from LSEG data August 9 at
02:21 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.90          -0.81          Beat
 Mar. 31 2024      -0.95          -0.90          Beat
 Dec. 31 2023      -0.86          -0.99          Missed
 Sep. 30 2023      -0.68          -0.71          Missed